ImmuCell Corporation (FRA:IUL)
Germany · Delayed Price · Currency is EUR 4.060
0.00 (0.00%)
At close: Nov 28, 2025
ImmuCell Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 27.77 | 26.49 | 17.47 | 18.57 | 19.24 | 15.34 | Upgrade | |
Revenue Growth (YoY) | 16.49% | 51.63% | -5.90% | -3.51% | 25.42% | 11.80% | Upgrade |
Cost of Revenue | 16 | 18.15 | 13.08 | 10.33 | 10.59 | 8.48 | Upgrade |
Gross Profit | 11.77 | 8.35 | 4.4 | 8.24 | 8.66 | 6.86 | Upgrade |
Selling, General & Admin | 5.94 | 5.68 | 5.22 | 5.45 | 4.23 | 3.89 | Upgrade |
Research & Development | 3.1 | 3.9 | 4.39 | 4.49 | 4.17 | 4.35 | Upgrade |
Operating Expenses | 9.04 | 9.58 | 9.62 | 9.95 | 8.4 | 8.24 | Upgrade |
Operating Income | 2.74 | -1.23 | -5.22 | -1.71 | 0.26 | -1.38 | Upgrade |
Interest Expense | -0.52 | -0.57 | -0.48 | -0.35 | -0.31 | -0.41 | Upgrade |
Interest & Investment Income | 0.16 | 0.08 | 0.1 | 0.15 | 0.02 | 0.03 | Upgrade |
Other Non Operating Income (Expenses) | 0 | - | 0 | 0 | - | - | Upgrade |
EBT Excluding Unusual Items | 2.38 | -1.72 | -5.6 | -1.9 | -0.04 | -1.77 | Upgrade |
Gain (Loss) on Sale of Assets | -0.06 | -0.02 | -0.01 | 0.01 | -0.03 | -0.04 | Upgrade |
Other Unusual Items | -0.41 | -0.41 | -0.53 | -0.59 | - | 0.77 | Upgrade |
Pretax Income | 2.34 | -2.15 | -5.77 | -2.49 | -0.07 | -1.03 | Upgrade |
Income Tax Expense | 0.01 | 0.01 | 0 | 0.01 | 0.01 | -0.01 | Upgrade |
Net Income | 2.32 | -2.16 | -5.77 | -2.49 | -0.08 | -1.02 | Upgrade |
Net Income to Common | 2.32 | -2.16 | -5.77 | -2.49 | -0.08 | -1.02 | Upgrade |
Shares Outstanding (Basic) | 9 | 8 | 8 | 8 | 8 | 7 | Upgrade |
Shares Outstanding (Diluted) | 9 | 8 | 8 | 8 | 8 | 7 | Upgrade |
Shares Change (YoY) | 14.38% | 5.42% | 0.03% | 2.01% | 5.25% | 5.78% | Upgrade |
EPS (Basic) | 0.26 | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 | Upgrade |
EPS (Diluted) | 0.26 | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 | Upgrade |
Free Cash Flow | 0.72 | -0.11 | -6.57 | -5.52 | -1.65 | -2.76 | Upgrade |
Free Cash Flow Per Share | 0.08 | -0.01 | -0.85 | -0.71 | -0.22 | -0.38 | Upgrade |
Gross Margin | 42.40% | 31.51% | 25.16% | 44.37% | 44.98% | 44.73% | Upgrade |
Operating Margin | 9.85% | -4.66% | -29.88% | -9.21% | 1.34% | -9.00% | Upgrade |
Profit Margin | 8.37% | -8.14% | -33.05% | -13.43% | -0.41% | -6.66% | Upgrade |
Free Cash Flow Margin | 2.58% | -0.41% | -37.59% | -29.72% | -8.60% | -17.97% | Upgrade |
EBITDA | 5.43 | 1.45 | -2.5 | 0.78 | 2.72 | 0.97 | Upgrade |
EBITDA Margin | 19.56% | 5.49% | -14.33% | 4.19% | 14.13% | 6.30% | Upgrade |
D&A For EBITDA | 2.7 | 2.69 | 2.72 | 2.49 | 2.46 | 2.35 | Upgrade |
EBIT | 2.74 | -1.23 | -5.22 | -1.71 | 0.26 | -1.38 | Upgrade |
EBIT Margin | 9.85% | -4.66% | -29.88% | -9.21% | 1.34% | -9.00% | Upgrade |
Effective Tax Rate | 0.61% | - | - | - | - | - | Upgrade |
Advertising Expenses | - | - | - | - | - | 0.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.